Kidney Transplantation in Patients with HIV

Overview

Journal Kidney360

Specialty Nephrology

Date 2022 Apr 4

PMID 35372947

Authors

Deirdre Sawinski

Affiliations

Soon will be listed here.

Abstract

Individuals with HIV are at increased risk for ESKD. Kidney transplantation is the best treatment for ESKD in the HIV+ population. Despite reduced access to transplantation, patients who are HIV+ have excellent outcomes and clearly benefit from receiving one. Common post-transplant complications and management concerns, including the optimal antiretroviral regimen, immunosuppression protocols, infectious prophylaxis, hepatitis C coinfection, metabolic complications, and malignancy are all discussed.

Citing Articles

Racial Disparities in Access to the Kidney Transplant Waitlist Among People with Human Immunodeficiency Virus.

Shelton B, Becker D, Maclennan P, Sen B, Budhwani H, Locke J AIDS Patient Care STDS. 2023; 37(8):394-402.

PMID: 37566535 PMC: 10457613. DOI: 10.1089/apc.2023.0037.

The first report of kidney transplantation in a human immunodeficiency virus-positive recipient in Thailand and literature review: Encouragement for developing countries in Southeast Asia.

Udomkarnjananun S, Naiyarakseree N, Townamchai N, Surinrat E, Tiankanon K, Banjongjit A SAGE Open Med Case Rep. 2021; 9:2050313X211024471.

PMID: 34211716 PMC: 8216421. DOI: 10.1177/2050313X211024471.

References

Sawinski D, Forde K, Locke J, Cohen J, Weldon J, Shults J . Race but not Hepatitis C co-infection affects survival of HIV individuals on dialysis in contemporary practice. Kidney Int. 2017; 93(3):706-715. DOI: 10.1016/j.kint.2017.08.015. View

Grulich A, van Leeuwen M, Falster M, Vajdic C . Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007; 370(9581):59-67. DOI: 10.1016/S0140-6736(07)61050-2. View

Locke J, Gustafson S, Mehta S, Reed R, Shelton B, Maclennan P . Survival Benefit of Kidney Transplantation in HIV-infected Patients. Ann Surg. 2016; 265(3):604-608. PMC: 5285482. DOI: 10.1097/SLA.0000000000001761. View

Cohen J, Locke J, Shelton B, Reed R, Mustian M, MacLennan P . Disparity in access to kidney allograft offers among transplant candidates with human immunodeficiency virus. Clin Transplant. 2018; 33(2):e13466. PMC: 6386602. DOI: 10.1111/ctr.13466. View

Shah A, Stelzle D, Lee K, Beck E, Alam S, Clifford S . Global Burden of Atherosclerotic Cardiovascular Disease in People Living With HIV: Systematic Review and Meta-Analysis. Circulation. 2018; 138(11):1100-1112. PMC: 6221183. DOI: 10.1161/CIRCULATIONAHA.117.033369. View

Gathogo E, Harber M, Bhagani S, Levy J, Jones R, Hilton R . Impact of Tacrolimus Compared With Cyclosporin on the Incidence of Acute Allograft Rejection in Human Immunodeficiency Virus-Positive Kidney Transplant Recipients. Transplantation. 2015; 100(4):871-8. DOI: 10.1097/TP.0000000000000879. View

Hirsch H, Randhawa P . BK polyomavirus in solid organ transplantation-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019; 33(9):e13528. DOI: 10.1111/ctr.13528. View

Stock P, Barin B, Hatano H, Rogers R, Roland M, Lee T . Reduction of HIV persistence following transplantation in HIV-infected kidney transplant recipients. Am J Transplant. 2014; 14(5):1136-41. PMC: 4012326. DOI: 10.1111/ajt.12699. View

Suarez J, Rosa R, Lorio M, Morris M, Abbo L, Simkins J . Pretransplant CD4 Count Influences Immune Reconstitution and Risk of Infectious Complications in Human Immunodeficiency Virus-Infected Kidney Allograft Recipients. Am J Transplant. 2016; 16(8):2463-72. PMC: 4956530. DOI: 10.1111/ajt.13782. View

10.

Lee D, Boyle S, Malat G, Kern C, Milrod C, DeBellis S . Barriers to listing for HIV-infected patients being evaluated for kidney transplantation. Transpl Infect Dis. 2017; 19(6). PMC: 5745286. DOI: 10.1111/tid.12777. View

11.

Kayler L, Xia Y, Friedmann P . Effect of HCV/HIV coinfection versus HCV monoinfection in kidney transplant recipients. Am J Transplant. 2015; 15(3):849-50. DOI: 10.1111/ajt.13080. View

12.

Axelrod D, Schnitzler M, Alhamad T, Gordon F, Bloom R, Hess G . The impact of direct-acting antiviral agents on liver and kidney transplant costs and outcomes. Am J Transplant. 2018; 18(10):2473-2482. PMC: 6409105. DOI: 10.1111/ajt.14895. View

13.

Uthman O, Nduka C, Watson S, Mills E, Kengne A, Jaffar S . Statin use and all-cause mortality in people living with HIV: a systematic review and meta-analysis. BMC Infect Dis. 2018; 18(1):258. PMC: 5987595. DOI: 10.1186/s12879-018-3162-1. View

14.

Malat G, Boyle S, Jindal R, Guy S, Xiao G, Harhay M . Kidney Transplantation in HIV-Positive Patients: A Single-Center, 16-Year Experience. Am J Kidney Dis. 2018; 73(1):112-118. DOI: 10.1053/j.ajkd.2018.02.352. View

15.

Triant V, Brown T, Lee H, Grinspoon S . Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system. J Clin Endocrinol Metab. 2008; 93(9):3499-504. PMC: 2567857. DOI: 10.1210/jc.2008-0828. View

16.

Sawinski D, Forde K, Eddinger K, Troxel A, Blumberg E, Tebas P . Superior outcomes in HIV-positive kidney transplant patients compared with HCV-infected or HIV/HCV-coinfected recipients. Kidney Int. 2015; 88(2):341-9. PMC: 5113138. DOI: 10.1038/ki.2015.74. View

17.

Ahuja T, Grady J, Khan S . Changing trends in the survival of dialysis patients with human immunodeficiency virus in the United States. J Am Soc Nephrol. 2002; 13(7):1889-93. DOI: 10.1097/01.asn.0000019773.43765.bf. View

18.

Durand C, Werbel W, Doby B, Brown D, Desai N, Malinis M . Clarifying the HOPE Act landscape: The challenge of donors with false-positive HIV results. Am J Transplant. 2019; 20(2):617-619. PMC: 7132607. DOI: 10.1111/ajt.15681. View

19.

Locke J, James N, Mannon R, Mehta S, Pappas P, Baddley J . Immunosuppression regimen and the risk of acute rejection in HIV-infected kidney transplant recipients. Transplantation. 2013; 97(4):446-50. DOI: 10.1097/01.TP.0000436905.54640.8c. View

20.

Abraham A, Althoff K, Jing Y, Estrella M, Kitahata M, Wester C . End-stage renal disease among HIV-infected adults in North America. Clin Infect Dis. 2014; 60(6):941-9. PMC: 4357817. DOI: 10.1093/cid/ciu919. View